Cesia Gallegos Kattan, MD, MHS
Assistant ProfessorCards
About
Research
Publications
2024
Tracking the pre-clinical progression of transthyretin amyloid cardiomyopathy using artificial intelligence-enabled electrocardiography and echocardiography.
Oikonomou EK, Sangha V, Vasisht Shankar S, Coppi A, Krumholz HM, Nasir K, Miller EJ, Gallegos-Kattan C, Al-Mallah MH, Al-Kindi S, Khera R. Tracking the pre-clinical progression of transthyretin amyloid cardiomyopathy using artificial intelligence-enabled electrocardiography and echocardiography. MedRxiv 2024 PMID: 39252891, DOI: 10.1101/2024.08.25.24312556.Peer-Reviewed Original ResearchThe Impact of Socioeconomic Status and Diagnostic Timeline on Clinical Outcomes in ATTR Cardiomyopathy
Chi K, Gallegos-Kattán C, Sikand N, Samsky M, Nanna M. The Impact of Socioeconomic Status and Diagnostic Timeline on Clinical Outcomes in ATTR Cardiomyopathy. Journal Of The American College Of Cardiology 2024, 84: e289-e290. PMID: 39505422, DOI: 10.1016/j.jacc.2024.07.050.Peer-Reviewed Original ResearchHigh-Sensitivity Troponin: Finding a Meaningful Delta
Wright C, Wright D, Hu J, Gallegos C. High-Sensitivity Troponin: Finding a Meaningful Delta. Journal Of Cardiovascular Development And Disease 2024, 11: 318. PMID: 39452288, PMCID: PMC11508916, DOI: 10.3390/jcdd11100318.Peer-Reviewed Original ResearchEuropean Society of CardiologyHs-cTnCardiac biomarkersMyocardial injuryFourth Universal Definition of Myocardial InfarctionHigh-sensitivity cardiac troponinUniversal Definition of Myocardial InfarctionChest pain syndromeAmerican College of Cardiology/American Heart AssociationHs-cTn assaysHs-cTn valuesFourth Universal DefinitionDefinition of myocardial infarctionClinical risk scoreAcute myocardial injurySociety of CardiologyStandard cardiac biomarkersInterpretation of dynamic changesChest painPain syndromeOptimal time frameCardiac troponinRule-OutHeart AssociationSymptom onsetEvaluating Ischemic Heart Disease in Women: Focus on Angina With Nonobstructive Coronary Arteries (ANOCA)
Maayah M, Latif N, Vijay A, Gallegos C, Cigarroa N, Martinez E, Mazure C, Miller E, Spatz E, Shah S. Evaluating Ischemic Heart Disease in Women: Focus on Angina With Nonobstructive Coronary Arteries (ANOCA). Journal Of The Society For Cardiovascular Angiography & Interventions 2024, 3: 102195. PMID: 39166160, PMCID: PMC11330936, DOI: 10.1016/j.jscai.2024.102195.Peer-Reviewed Original ResearchIschemic heart diseaseNonobstructive coronary arteriesCoronary artery diseaseArtery diseaseObstructive coronary artery diseaseCoronary arteryLong-term cardiovascular prognosisHeart diseaseSuspected ischemic heart diseaseAtherosclerotic coronary artery diseaseCoronary vasomotor disordersPretest probability of diseasePragmatic diagnostic algorithmExpert consensus documentEvaluating ischemic heart diseaseImpact quality of lifeQuality of lifeSymptomatic patientsPretest probabilityANOCACardiovascular prognosisVasomotor disordersDiagnostic evaluationPersistent symptomsDiagnostic strategiesUnlocking Diversity in Cardiovascular Clinical Research: Lessons from the Screening for Cardiac Amyloidosis With Nuclear Imaging in a Minority Populations Study
Wardhere A, Bampatsias D, Cohn E, Fine D, Freitas C, Gallegos C, Helmke S, Ionescu N, Ivrose J, Rodriguez C, Sabogal N, Fils S, Henry T, Teruya S, Ullah I, Kurian D, Raiszadeh F, Miller E, Ruberg F, Maurer M. Unlocking Diversity in Cardiovascular Clinical Research: Lessons from the Screening for Cardiac Amyloidosis With Nuclear Imaging in a Minority Populations Study. Journal Of Cardiac Failure 2024, 30: 1507-1511. PMID: 38740174, PMCID: PMC11551251, DOI: 10.1016/j.cardfail.2024.04.019.Peer-Reviewed Original ResearchDuration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Network Meta-analysis
Park D, Hu J, Campbell G, Goldwag K, Kelsey M, Altin S, Gallegos-Kattán C, Nanna M. Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Network Meta-analysis. Journal Of The Society For Cardiovascular Angiography & Interventions 2024, 3: 101859. PMID: 39131993, PMCID: PMC11307649, DOI: 10.1016/j.jscai.2024.101859.Peer-Reviewed Original ResearchMonths of DAPTDuration of dual antiplatelet therapyNet adverse clinical eventsType 2 diabetes mellitusDual antiplatelet therapyAcute coronary syndromeRandomized Controlled TrialsSensitivity analysis of trialsPercutaneous coronary interventionCoronary interventionNo significant differenceAntiplatelet therapyAnalysis of trialsCoronary syndromeControlled TrialsMeta-analysis of patientsStent thrombosisMeta-analysisDAPT durationClinicians greater flexibilityStudy-level meta-analysisOptimal duration of dual antiplatelet therapyHigher risk of adverse eventsPostpercutaneous coronary interventionRisk of adverse events18F-FDG PET/CT and radiolabeled leukocyte SPECT/CT imaging for the evaluation of cardiovascular infection in the multimodality context ASNC Imaging Indications (ASNC I2) Series Expert Consensus Recommendations from ASNC, AATS, ACC, AHA, ASE, EANM, HRS, IDSA, SCCT, SNMMI, and STS
. 18F-FDG PET/CT and radiolabeled leukocyte SPECT/CT imaging for the evaluation of cardiovascular infection in the multimodality context ASNC Imaging Indications (ASNC I2) Series Expert Consensus Recommendations from ASNC, AATS, ACC, AHA, ASE, EANM, HRS, IDSA, SCCT, SNMMI, and STS. Journal Of Nuclear Cardiology 2024, 34: 101786. PMID: 38472038, DOI: 10.1016/j.nuclcard.2023.101786.Peer-Reviewed Original ResearchStrategies to attract early career physicians to the field of nuclear cardiology.
Gallegos C, Divakaran S. Strategies to attract early career physicians to the field of nuclear cardiology. J Nucl Cardiol 2024, 32: 101784. PMID: 38195268, DOI: 10.1016/j.nuclcard.2023.101784.Commentaries, Editorials and Letters
2022
Radiopharmaceutical supply disruptions and the use of 99mTc-hydroxymethylene diphosphonate as an alternative to 99mTc-pyrophosphate for the diagnosis of transthyretin cardiac amyloidosis: An ASNC Information Statement
Miller EJ, Campisi R, Shah NR, McMahon S, Cuddy S, Gallegos-Kattan C, Maurer MS, Damy T, Slart RHJA, Bhatia K, Einstein AJ. Radiopharmaceutical supply disruptions and the use of 99mTc-hydroxymethylene diphosphonate as an alternative to 99mTc-pyrophosphate for the diagnosis of transthyretin cardiac amyloidosis: An ASNC Information Statement. Journal Of Nuclear Cardiology 2022, 29: 2748-2760. PMID: 35838892, PMCID: PMC9285188, DOI: 10.1007/s12350-022-03059-5.Peer-Reviewed Original Research
2021
Non-steroidal treatment of cardiac sarcoidosis: A systematic review
Gallegos C, Oikonomou EK, Grimshaw A, Gulati M, Young BD, Miller EJ. Non-steroidal treatment of cardiac sarcoidosis: A systematic review. IJC Heart & Vasculature 2021, 34: 100782. PMID: 33997256, PMCID: PMC8105294, DOI: 10.1016/j.ijcha.2021.100782.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsNon-steroidal treatmentSteroid-sparing agentCardiac sarcoidosisSafety profileSystematic reviewCases of CSDisease-modifying antirheumatic agentsManagement of CSActive cardiac sarcoidosisAnti-inflammatory managementAverage corticosteroid doseHigher-line treatmentsMaintenance steroid doseFirst-line treatmentSide effect profileSteroid-sparing therapiesInception of databasesLong-term useCorticosteroid doseSteroid doseBiologic DMARDsImmunosuppressive therapyTreatment initiationEffect profileImmunosuppressive agents
Academic Achievements & Community Involvement
Clinical Care
Overview
Cesia Gallegos, MD, is a cardiologist who specializes in taking care of patients with a specific group of heart diseases called infiltrative cardiomyopathies, such as cardiac amyloid and sarcoid, which can cause arrhythmias, heart failure, and other cardiac dysfunctions. She also specializes in advanced cardiac imaging.
The intersection of advanced cardiovascular imaging as it pertains to treating a variety of cardiac conditions is her main passion. She says she chose this field after seeing the tremendous advances in the understanding of the function of the heart without any surgeries or invasive operations.
When patients have a heart condition they don’t understand, they can be very anxious at their first visit with a cardiologist, Dr. Gallegos explains. “Some patients really just need to hear that they aren’t dying,” she says. “First, I tell them we’re going to figure out why they are not feeling well and take it from there.”
Before she begins to address patients’ diseases, Dr. Gallegos asks questions to get to know them as individuals. “I ask about their friends or how they spend their weekends. I want them to leave knowing that someone cares about them as a whole and not just about their condition,” she says. “It’s rewarding when they leave with a smile, even though they’re sick.”
Outside of the clinic, Dr. Gallegos conducts clinical research in the use of nuclear cardiology modalities as they apply to coronary artery disease and cardiac sarcoidosis and amyloidosis. Specifically, her current research focuses in a unique type of stress test that allows doctors to non-invasively study blood flow through coronary arteries to detect blockages. Typically, these blockages are only found using a special invasive test called an angiogram. Additionally, she is an active part of multiple studies and clinical trials focused on advancing the knowledge and treatment of infiltrative cardiomyopathies.
Clinical Specialties
Fact Sheets
Cardiac Amyloidosis
Learn More on Yale MedicineCardiomyopathies
Learn More on Yale MedicineAmyloidosis
Learn More on Yale MedicineSarcoidosis
Learn More on Yale Medicine
Board Certifications
Nuclear Cardiology
- Certification Organization
- Certification Board of Nuclear Cardiology
- Original Certification Date
- 2019
Yale Medicine News
News
News
- November 18, 2025
Upcoming Conference: Obesity and Genetic Heart Disease in the Era of Preventive Cardiology
- January 03, 2025
Building Clinical Capacity in Cardiovascular Medicine Across the Caribbean
- September 18, 2024
Drs. Gallegos and Akintoye Named New Leaders of Yale’s Advanced Cardiac Imaging Fellowship Program
- July 03, 2024
Gallegos and Feher Join the Journal of Nuclear Cardiology’s Early Career Editorial Board
Get In Touch
Contacts
Locations
Patient Care Locations
Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.